The Nurse Practitioner Role in Evidence-Based Medication Strategies

Journal of Perianesthesia Nursing

Volumn 23, Issue 2, 2008, Pages 87-93

  Kidik, Patricia J ^a   Holbrook, Kathleen F ^a  

^a NONE

Author keywords

evidence based medication strategies; nurse practitioners; preoperative evaluation

Indexed keywords

ARTICLE; EVIDENCE BASED MEDICINE; HUMAN; NURSE ATTITUDE; NURSE PRACTITIONER;

EVIDENCE-BASED MEDICINE; HUMANS; NURSE PRACTITIONERS; NURSE'S ROLE;

EID: 40949134637     PISSN: 10899472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jopan.2007.09.013     Document Type: Article

References (29)

1. Guido B.A. The role of a nurse practitioner in an ambulatory surgery unit. AORN J 79 (2004) 606,608-610,612-615
2. Wadsworth L., Smith A., and Waterman H. The nurse practitioner's role in day case pre-operative assessment. Nurs Stand 16 (2002) 41-44
3. Barnett J.S. An emerging role for nurse practitioners-Preoperative assessment. AORN J 82 (2005) 825-834
4. Correll D.J., Bader A.M., Hull M.W., et al. Value of preoperative clinic visits in identifying issues with potential impact on operating room efficiency. Anesthesiology 105 (2006) 1254-1259
5. Hepner D.L., Bader A.M., Hurwitz S., et al. Patient satisfaction with preoperative assessment in a preoperative assessment testing clinic. Anesth Analg 98 (2004) 1099-1105
6. DeBourgh G.A. Champions for evidence-based practice: A critical role for advanced practice nurses. AACN Clin Issues Adv Pract Acute Crit Care 12 (2001) 491-508
7. Surgical Care Improvement Project (SCIP). Available at: http://www.medqic.org/scip. Accessed May 30, 2007.
8. The Joint Commission. Home page. Available at: http://www.jointcommission.org/. Accessed May 21, 2007.
9. Mangano D.T., Layug E.L., Wallace A., et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 335 (1996) 1713-1720
10. Fleisher L.A., Beckman J.A., Brown K.A., et al. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: Focused update on perioperative beta-blocker therapy-A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 113 (2006) 2662-2674
11. Poldermans D., Boersma E., Bax J.J., et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high risk patients undergoing vascular surgery. N Engl J Med 341 (1999) 1789-1794
12. Poise Trial Investigators, Devereaux P.J., Yang H., Guyatt G.H., et al. Rationale, design, and organization of the perioperative ischemic evaluation (POISE) trial: A randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery. Am Heart J 152 (2006) 223-230
13. Schouten O., Poldermans D., Visser L., et al. Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality in high risk patients undergoing noncardiac surgery: Rationale and design of the DECREASE-IV study. Am Heart J 148 (2004) 1047-1052
14. Redelmeier D., Scales D., and Kopp A. Beta blockers for elective surgery in elderly patients: Population based, retrospective cohort study. BMJ 331 (2005) 932
15. Bick R.L., and Kaplan H. Syndromes of thrombosis and hypercoagulability. Congenital and acquired causes of thrombosis. Med Clin North America 82 (1998) 409-458
16. Fiumara K. "Prevention of VTE Among Hospitalized Patients: Electronic Alerts vs. Human Alerts" (February 15, 2007), Brigham and Women's Hospital, Boston, MA
17. Geerts W.H., Pineo G.F., Heit J.A., et al. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 3 Suppl (2004) 338S-400S
18. Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). Int Angiol 25 (2006) 101-161
19. Goldhaber S.Z., Dunn K., and MacDougall R.C. New onset of venous thromboembolism among hospitalized patients at Brigham and Women's Hospital is caused more often by prophylaxis failure than by withholding treatment. Chest 118 (2000) 1680-1684
20. Goldhaber S.Z., and Tapson V.F. DVT FREE Steering Committee. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol 15 93 (2004) 259-262
21. Kearon C. Natural history of venous thromboembolism. Circulation 107 (2003) I22-I30
22. Franzeck U.K., Schalch I., Jager K.A., et al. Prospective 12-year follow-up study of clinical and hemodynamic sequelae of deep vein thrombosis in low-risk patients (Zurich Study). Circulation 93 (1996) 74-79
23. Prandoni P., Lensing A.W., Cogo A., et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 125 (1996) 1-7
24. Lindner D.J., Edwards J.M., Phinney E.S., et al. Long-term hemodynamic and clinical sequellae of lower extremity deep vein thrombosis. J Vasc Surg 4 (1986) 436-442
25. Bergqvist D., Jendteg S., Johansen L., et al. Cost of long-term complications of deep venous thrombosis of the lower extremities: An analysis of a defined patient population in Sweden. Ann Intern Med 126 (1997) 454-457
26. Heit J.A., Rooke T.W., Silverstein M.D., et al. Trends in the incidence of venous stasis syndrome and venous ulcer: A 25-year population-based study. J Vasc Surg 33 (2001) 1022-1027
27. Kahn S.R., Hirsch A., and Shrier I. Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med 162 (2002) 1144-1148
28. Caprini J.A., Botteman M.F., Stephens J.M., et al. Economic burden of long-term complications of deep vein throbosis after total hip replacement surgery in the United States. Value Health 6 (2003) 59-74
29. Mathias J.M. Preventing venous thromboembolism. OR Manager 22 (2006) 18-23